神经介入治疗患者颅内感染病原菌分布与耐药性分析

Nerve involvement in treatment of intracranial infection pathogenic bacteria distribution and drug susceptibility analysis

  • 摘要: 目的 对神经介入治疗患者颅内感染病原菌的分布及药敏性进行分析,为临床治疗提供参考依据。方法 选取医院2010年8月-2015年10月行神经介入治疗患者845例,脊髓穿刺法获取脑脊液标本,采用法国生物梅里埃公司VITEK-2 Compact仪器进行菌种鉴定,并进行耐药性分析。结果 845例患者中分离出病原菌276株,其中革兰阴性菌138株占50.00%,革兰阳性菌86株占31.16%,真菌52株占18.84%;鲍氏不动杆菌、铜绿假单胞菌及肺炎克雷伯菌对氨苄西林、青霉素耐药率100.00%,肺炎克雷伯菌对亚胺培南、美罗培南的耐药率为10.71%、7.14%;金黄色葡萄球菌及表皮葡萄球菌对青霉素、头孢西丁的耐药率为100.00%;新型隐球菌对伏立康唑、氟康唑、两性霉素B敏感。结论 神经内科介入治疗患者颅内感染以革兰阴性菌为主要病原菌,对多种抗感染类药物耐药性较高。

     

    Abstract: OBJECTIVE Interventional treatment from hair nerve distribution intracranial infection pathogens and drug sensitivity of the investigation and analysis,to provide reference evidence for clinical treatment.METHODS Select the hospital in August 2010- October 2015 nerve involvement after intracranial infection in patients treated845 cases,spinal puncture to obtain cerebrospinal fluid specimens using Vitek 2Compact type of bacteria identification.RESULTS 276 pathogens isolated were gram-negative bacteria 131,accounting for 47.46%,Acinetobacter baumannii 47(17.03%),Klebsiella pneumoniae 28(10.14%),Pseudomonas aeruginosa 21(7.61%);grampositive bacteria 93,accounting for 33.69%,Staphylococcus aureus 32(11.6%),Staphylococcus epidermidis 24(8.70%);fungi 52,accounting for 18.84%,mainly Cryptococcus neoformans 46(16.67%).Resistance rates of A.baumannii,P.aeruginosaand K.pneumoniae resistance rates to ampicillin,penicillin were 100.0%,and K.pneumoniae resistance rate to imipenem was 8.9% and 5.6%.Resistance rates of S.aureus and Staphylococcus epidermidis to penicillin,cefoxitin were 100.0%.C.neoformans did show resistance to voriconazole,fluconazole,amphotericin B.CONCLUSION Gram-negative bacteria are the main pathogens in neurology intervention in patients with intracranial infection,drug resistance to a variety of infections is higher.

     

/

返回文章
返回